Precision Biosciences (DTIL) EPS (Basic) Growth (3y) (2021 - 2026)
Precision Biosciences (DTIL) EPS (Basic) Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | 64.84% |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 18.44% |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 37.21% |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 36.73% |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | -26.87% |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 67.51% |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | -38.31% |
| 10 | Precision Biosciences | 226.25 Mn | 138.70 Mn | - | -97.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.68% |
| Mar 31, 2026 | 51.20% |
| Dec 31, 2025 | 32.53% |
| Sep 30, 2025 | -1.54% |
| Jun 30, 2025 | 49.77% |
| Mar 31, 2025 | 48.57% |
| Dec 31, 2024 | 39.40% |
| Sep 30, 2024 | 28.64% |
| Jun 30, 2024 | -39.63% |
| Mar 31, 2024 | 60.92% |
| Dec 31, 2023 | 62.42% |
| Sep 30, 2023 | 27.31% |
| Jun 30, 2023 | 51.40% |
| Mar 31, 2023 | 44.25% |
| Dec 31, 2022 | 40.85% |
| Sep 30, 2022 | 45.63% |
| Jun 30, 2022 | -0.35% |
| Mar 31, 2022 | 26.59% |
| Dec 31, 2021 | 19.82% |
| Sep 30, 2021 | 15.60% |